$OMEX
ODYSSEY MARINE EXPLORATION INC

2017 Q3 Form 10-K Financial Statement

#000119312518095089 Filed on March 26, 2018

View on sec.gov

Income Statement

Concept 2017 Q3 2017 2016 Q4
Revenue $11.85K $1.248M $0.00
YoY Change -99.59% -73.34% -100.0%
Cost Of Revenue $0.00
YoY Change
Gross Profit $11.85K $1.250M
YoY Change -99.59%
Gross Profit Margin 100.0% 100.12%
Selling, General & Admin $1.863M $6.167M $3.330M
YoY Change -15.06% -22.51% -37.52%
% of Gross Profit 15718.98% 493.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $170.0K $760.8K $220.0K
YoY Change -29.17% -28.45% -33.33%
% of Gross Profit 1434.12% 60.86%
Operating Expenses $1.863M $6.167M $3.330M
YoY Change -15.06% -22.51% -37.41%
Operating Profit -$2.470M -$8.357M
YoY Change 12.41% -20.79%
Interest Expense $638.9K $2.727M -$870.0K
YoY Change 6.68% 13.78% -66.28%
% of Operating Profit
Other Income/Expense, Net -$635.8K -$2.664M $80.00K
YoY Change 5.93% -280.88% -80.49%
Pretax Income -$3.106M -$11.02M -$3.130M
YoY Change 11.02% 21.4% -354.47%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.251M -$7.759M -$2.410M
YoY Change 5.57% 22.85% -208.84%
Net Earnings / Revenue -18990.19% -621.52%
Basic Earnings Per Share -$0.27
Diluted Earnings Per Share -$0.27 -$945.2K -$316.7K
COMMON SHARES
Basic Shares Outstanding 8.389M shares 8.210M 7.600M shares
Diluted Shares Outstanding 8.389M shares

Balance Sheet

Concept 2017 Q3 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.340M $1.110M $1.660M
YoY Change 152.83% -33.13% -25.89%
Cash & Equivalents $1.342M $1.110M $1.663M
Short-Term Investments
Other Short-Term Assets $242.1K $500.0K $609.5K
YoY Change -41.82% -19.35% 21.24%
Inventory
Prepaid Expenses $582.6K
Receivables $263.7K $190.0K $473.8K
Other Receivables $50.00K $40.00K $40.00K
Total Short-Term Assets $1.858M $1.850M $2.756M
YoY Change -16.89% -32.97% -22.27%
LONG-TERM ASSETS
Property, Plant & Equipment $749.8K $590.0K $1.795M
YoY Change -62.85% -57.25% -36.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $532.5K $530.0K $532.5K
YoY Change 0.0% -44.21% -1.5%
Total Long-Term Assets $1.282M $1.120M $2.328M
YoY Change -49.73% -51.72% -30.87%
TOTAL ASSETS
Total Short-Term Assets $1.858M $1.850M $2.756M
Total Long-Term Assets $1.282M $1.120M $2.328M
Total Assets $3.140M $2.970M $5.084M
YoY Change -34.39% -41.54% -26.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.113M $2.400M $1.397M
YoY Change 0.66% 71.43% -10.86%
Accrued Expenses $6.070M $6.550M $5.078M
YoY Change 28.33% 28.94% 19.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $23.15M $24.36M $20.73M
YoY Change 30.35% 17.51% 37.65%
Total Short-Term Liabilities $31.33M $33.31M $27.21M
YoY Change 27.45% 22.42% 10.25%
LONG-TERM LIABILITIES
Long-Term Debt $3.000M $3.000M $4.340M
YoY Change -29.91% -30.88% 38.22%
Other Long-Term Liabilities $4.640M $4.640M $4.640M
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Liabilities $7.644M $7.640M $8.979M
YoY Change -14.36% -14.92% 15.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.33M $33.31M $27.21M
Total Long-Term Liabilities $7.644M $7.640M $8.979M
Total Liabilities $38.97M $25.58M $36.19M
YoY Change 16.32% 6.27% 11.47%
SHAREHOLDERS EQUITY
Retained Earnings -$233.3M -$227.0M
YoY Change 3.91% 2.86%
Common Stock $212.0M $208.0M
YoY Change 2.31% 1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$21.31M -$22.61M -$18.99M
YoY Change
Total Liabilities & Shareholders Equity $3.140M $2.970M $5.084M
YoY Change -34.39% -41.54% -26.46%

Cashflow Statement

Concept 2017 Q3 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$2.251M -$7.759M -$2.410M
YoY Change 5.57% 22.85% -208.84%
Depreciation, Depletion And Amortization $170.0K $760.8K $220.0K
YoY Change -29.17% -28.45% -33.33%
Cash From Operating Activities -$1.580M -$5.851M -$1.790M
YoY Change 29.51% -29.55% 0.56%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $30.00K $80.00K $0.00
YoY Change -60.0%
Cash From Investing Activities $30.00K $80.00K $0.00
YoY Change -142.86% 13.77% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.420M 5.216M 2.920M
YoY Change -14300.0% -31.87% 33.33%
NET CHANGE
Cash From Operating Activities -1.580M -5.851M -1.790M
Cash From Investing Activities 30.00K 80.00K 0.000
Cash From Financing Activities 1.420M 5.216M 2.920M
Net Change In Cash -130.0K -554.5K 1.130M
YoY Change -90.0% -4.19% 182.5%
FREE CASH FLOW
Cash From Operating Activities -$1.580M -$5.851M -$1.790M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$1.580M -$5.851M -$1.790M
YoY Change 37.39% -30.64% 1.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY1998Q2 omex Percentage Of Proceeds From Shipwrecks Receivable Under Agreement
PercentageOfProceedsFromShipwrecksReceivableUnderAgreement
0.05 pure
CY2002Q4 omex Percentage Of Proceeds From Shipwrecks Receivable Under Agreement
PercentageOfProceedsFromShipwrecksReceivableUnderAgreement
0.05 pure
CY2011Q4 omex Class Of Warrant Or Right Warrants Issued
ClassOfWarrantOrRightWarrantsIssued
108507 shares
CY2011Q4 omex Number Of Securities Called By Warrants Or Rights Upon Additional Financing
NumberOfSecuritiesCalledByWarrantsOrRightsUponAdditionalFinancing
36169 shares
CY2012Q2 omex Class Of Warrant Or Right Warrants Issued
ClassOfWarrantOrRightWarrantsIssued
260417 shares
CY2012Q2 omex Number Of Securities Called By Warrants Or Rights Upon Additional Financing
NumberOfSecuritiesCalledByWarrantsOrRightsUponAdditionalFinancing
36169 shares
CY2014Q3 omex Fair Value Assumptions Quoted Price
FairValueAssumptionsQuotedPrice
2.50
CY2014Q4 omex Fair Value Assumptions Quoted Price
FairValueAssumptionsQuotedPrice
2.50
CY2015Q4 omex Fair Value Of Assets Assigned To Debt Extinguished
FairValueOfAssetsAssignedToDebtExtinguished
19125131
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8466909 shares
CY2016Q2 us-gaap Capitalized Costs Asset Retirement Costs
CapitalizedCostsAssetRetirementCosts
66329
CY2010Q4 omex Class Of Warrant Or Right Warrants Issued
ClassOfWarrantOrRightWarrantsIssued
150000 shares
CY2014Q4 omex Fair Value Assumptions Quoted Price
FairValueAssumptionsQuotedPrice
2.50
CY2016Q3 us-gaap Accounts Payable Interest Bearing Interest Rate
AccountsPayableInterestBearingInterestRate
0.12 pure
CY2016Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
553072
CY2016Q3 omex Collateral Asset Carrying Value
CollateralAssetCarryingValue
0
CY2017Q2 dei Entity Public Float
EntityPublicFloat
28500000
CY2013Q4 omex Fair Value Assumptions Quoted Price
FairValueAssumptionsQuotedPrice
2.50
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3143550
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
307791 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.04
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
19100000
CY2015Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
13500000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2241317
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
69481041
CY2015Q4 us-gaap Notes Payable
NotesPayable
23466108
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
275735 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
27.48
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
375283 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.04
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-25549008
CY2015Q4 omex Carrying Value Of Assets Assigned To Debt Extinguished
CarryingValueOfAssetsAssignedToDebtExtinguished
13513223
CY2015Q4 omex Loan Payable Carrying Value In Excess Of Fair Value
LoanPayableCarryingValueInExcessOfFairValue
4340977
CY2015Q4 omex Fair Value Of Assets Assigned To Debt Extinguished
FairValueOfAssetsAssignedToDebtExtinguished
19125131
CY2015Q4 omex Fair Value Assumptions Linked Common Shares
FairValueAssumptionsLinkedCommonShares
130208 shares
CY2015Q4 omex Fair Value Assumptions Quoted Price
FairValueAssumptionsQuotedPrice
2.50
CY2015Q4 omex Share Based Compensation Awards Options Estimated Weighted Average Grant Date Fair Value
ShareBasedCompensationAwardsOptionsEstimatedWeightedAverageGrantDateFairValue
8.52
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2345729
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5078125
CY2016Q4 us-gaap Assets Current
AssetsCurrent
2755911
CY2016Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
532500
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
473806
CY2016Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1300000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
544412
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15809774
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
207962346
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1397349
CY2016Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
393715
CY2016Q4 us-gaap Assets
Assets
5083665
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1662643
CY2016Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1500000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7718366 shares
CY2016Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
17188699
CY2016Q4 us-gaap Liabilities
Liabilities
36186532
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5083665
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2016Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
0 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7718366 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
772
CY2016Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
2391857
CY2016Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
26846
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4643750
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
532500
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1687214
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8979251
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27207281
CY2016Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
4335501
CY2016Q4 us-gaap Loans Payable
LoansPayable
25067308
CY2016Q4 us-gaap Loans Payable Current
LoansPayableCurrent
20731807
CY2016Q4 us-gaap Minority Interest
MinorityInterest
-12115547
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
609462
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
532500
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24984166 shares
CY2016Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
582616
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1795254
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17605028
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226950438
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16633
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16633
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
300751 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.30
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
332415 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.55
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-18987320
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-31102867
CY2016Q4 omex Accrued Other Operating Expenses Current
AccruedOtherOperatingExpensesCurrent
60927
CY2016Q4 omex Marine Asset Held For Sale
MarineAssetHeldForSale
416329
CY2016Q4 omex Fair Value Assumptions Quoted Price
FairValueAssumptionsQuotedPrice
1.25
CY2016Q4 omex Share Based Compensation Awards Options Estimated Weighted Average Grant Date Fair Value
ShareBasedCompensationAwardsOptionsEstimatedWeightedAverageGrantDateFairValue
1.75
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6551335
CY2017Q4 us-gaap Assets Current
AssetsCurrent
1846110
CY2017Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
532500
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
800000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
232380
CY2017Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
500000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
329640
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16145082
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
212103344
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2396835
CY2017Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
249247
CY2017Q4 us-gaap Assets
Assets
2972426
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1108193
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8466909 shares
CY2017Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
0 shares
CY2017Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
0
CY2017Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
3402329
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8466909 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
847
CY2017Q4 us-gaap Contractual Obligation
ContractualObligation
3402329
CY2017Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
0
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
152505
CY2017Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
1310446
CY2017Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
0
CY2017Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
0
CY2017Q4 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
0
CY2017Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
147552
CY2017Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
1387970
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
4056337
CY2017Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
23841
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49235133
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
102825
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
43155
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4643750
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1316178
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
152505
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
532500
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1871071
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2017Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
16738898
CY2017Q4 us-gaap Liabilities
Liabilities
40955362
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2972426
CY2017Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7643750
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33311612
CY2017Q4 us-gaap Loans Receivable With Variable Rates Of Interest1
LoansReceivableWithVariableRatesOfInterest1
0
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
3000000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0
CY2017Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
3000000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3000000
CY2017Q4 us-gaap Loans Payable
LoansPayable
27363442
CY2017Q4 us-gaap Loans Payable Current
LoansPayableCurrent
24363442
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
0
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0
CY2017Q4 us-gaap Minority Interest
MinorityInterest
-15377217
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
495527
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Receivable Current
OperatingLeasesFutureMinimumPaymentsReceivableCurrent
0
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Receivable In Four Years
OperatingLeasesFutureMinimumPaymentsReceivableInFourYears
0
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
0
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Receivable Thereafter
OperatingLeasesFutureMinimumPaymentsReceivableThereafter
0
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
532500
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
0
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Receivable In Five Years
OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears
0
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
0
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24984166 shares
CY2017Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
471686
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
593816
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16738898
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10010
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-234709910
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
247817 shares
CY2017Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
16.72
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
247817 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.76
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
247817 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.76
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-22605719
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-37982936
CY2017Q4 omex Long Term Debt Maturities Repayments Of Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfInterestInYearFour
0
CY2017Q4 omex Long Term Debt Maturities Repayments Of Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestInYearThree
0
CY2017Q4 omex Revenue Participation Agreement Value
RevenueParticipationAgreementValue
15000000
CY2017Q4 omex Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedExpenses
285295
CY2017Q4 omex Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards
DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwards
44772169
CY2017Q4 omex Long Term Debt Maturities Repayments Of Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo
402329
CY2017Q4 omex Accrued Other Operating Expenses Current
AccruedOtherOperatingExpensesCurrent
45040
CY2017Q4 omex Long Term Debt Maturities Repayments Of Interest In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfInterestInNextTwelveMonths
0
CY2017Q4 omex Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
11490
CY2017Q4 omex Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accounts Receivable
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccountsReceivable
156538
CY2017Q4 omex Deposits To Fund Conservation And Documentation
DepositsToFundConservationAndDocumentation
100000
CY2017Q4 omex Long Term Debt Maturities Repayments Of Interest After Year Five
LongTermDebtMaturitiesRepaymentsOfInterestAfterYearFive
0
CY2017Q4 omex Repayments Of Interest
RepaymentsOfInterest
402329
CY2017Q4 omex Working Capital Deficit
WorkingCapitalDeficit
31500000
CY2017Q4 omex Long Term Debt Maturities Repayments Of Interest In Year Five
LongTermDebtMaturitiesRepaymentsOfInterestInYearFive
0
CY2017Q4 omex Fair Value Assumptions Linked Common Shares
FairValueAssumptionsLinkedCommonShares
130208 shares
CY2017Q4 omex Redeemable Preferred Stock Outstanding
RedeemablePreferredStockOutstanding
0 shares
CY2017Q4 omex Share Based Compensation Awards Options Estimated Weighted Average Grant Date Fair Value
ShareBasedCompensationAwardsOptionsEstimatedWeightedAverageGrantDateFairValue
0.00
CY2017Q4 omex Deferred Tax Liabilities Reserve For Accounts Receivable Gain Loss
DeferredTaxLiabilitiesReserveForAccountsReceivableGainLoss
6525
CY2016Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.50000 pure
CY2015Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.16666 pure
CY2016Q1 omex Share Purchase Price
SharePurchasePrice
1.00
CY2016Q2 us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
200000
CY2016Q2 omex Vessel Assets Sold And Consideration Received In Kind
VesselAssetsSoldAndConsiderationReceivedInKind
350000
CY2016Q3 omex Threshold Gross Revenue Percentage Of Collateral Asset Treated As Debt
ThresholdGrossRevenuePercentageOfCollateralAssetTreatedAsDebt
0.15 pure
CY2016Q3 omex Net Proceeds Percentage Of Collateral Asset Treated As Debt
NetProceedsPercentageOfCollateralAssetTreatedAsDebt
0.50 pure
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2348744
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
505491 shares
CY2015 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
6.36
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-902233
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1447331
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2015 us-gaap Costs And Expenses
CostsAndExpenses
26854365
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2015 us-gaap Depreciation
Depreciation
1419295
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.46
CY2015 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
891345
CY2015 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1175971
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
5611907
CY2015 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-29404
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6190436
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4900061
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-380085
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-184257
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1854717
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
615991
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2024299
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2278411
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1189123
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-265077
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-21251245
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3503353
CY2015 us-gaap Interest Expense
InterestExpense
4551799
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
151922
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
67422
CY2015 us-gaap Interest Paid
InterestPaid
1419224
CY2015 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
137
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
799589
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17164207
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15462385
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-18207163
CY2015 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3044082
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-21524114
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
272869
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
388595
CY2015 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
2000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48411
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
850000
CY2015 us-gaap Profit Loss
ProfitLoss
-21251245
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
16750001
CY2015 us-gaap Repayments Of Debt
RepaymentsOfDebt
1808344
CY2015 us-gaap Revenues
Revenues
5330251
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1943709
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
2697365
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11458528
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
70174 shares
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
32.88
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.48
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1449216
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
137667 shares
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2015 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7413602 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7413602 shares
CY2015 omex Undiscounted Future Cash Flow Amount
UndiscountedFutureCashFlowAmount
3449632
CY2015 omex Payments For Proceeds From Restricted Cash Held As Collateral
PaymentsForProceedsFromRestrictedCashHeldAsCollateral
-520728
CY2015 omex Operations And Research Expense
OperationsAndResearchExpense
11428506
CY2015 omex Common Stock Issued For Subsidiary Stock Option Settlement
CommonStockIssuedForSubsidiaryStockOptionSettlement
2520000
CY2015 omex Expedition Charter Revenue
ExpeditionCharterRevenue
3328190
CY2015 omex Exhibit Revenue
ExhibitRevenue
58352
CY2015 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-18207163
CY2015 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
7413602 shares
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
833985
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
225324 shares
CY2017 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
3.98
CY2017 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2014-04-13
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-554450
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2017 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
50000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
9605570
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Depreciation
Depreciation
760766
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.95
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Entity Registrant Name
EntityRegistrantName
ODYSSEY MARINE EXPLORATION INC
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0000798528
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
289328
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3718058
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
28258724
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1097681
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-110667
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
711679
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-241426
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1881977
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
384060
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-113922
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11021142
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-24043997
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
999488
CY2017 us-gaap Interest Expense
InterestExpense
2727235
CY2017 us-gaap Interest Paid
InterestPaid
622055
CY2017 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
112
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
80000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5850682
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5216232
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-7759472
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3261670
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-8357093
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
63074
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
80000
CY2017 us-gaap Profit Loss
ProfitLoss
-11021142
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2664049
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5625000
CY2017 us-gaap Professional Fees
ProfessionalFees
227000
CY2017 us-gaap Repayments Of Debt
RepaymentsOfDebt
408768
CY2017 us-gaap Revenues
Revenues
1248477
CY2017 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
11854
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
725875
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2017 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y7M21D
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6167181
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2015-08-31
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
84598 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
35.59
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
231952
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2017 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.08333 pure
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2017 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2017 dei Trading Symbol
TradingSymbol
OMEX
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8209539 shares
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-20245908
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Management uses estimates and assumptions in preparing these consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used.</p> </div>
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8209539 shares
CY2017 omex Payment For One Time Revenue Distribution
PaymentForOneTimeRevenueDistribution
12986
CY2017 omex Senior Convertible Debit Interest Settled With Common Stock Issuance
SeniorConvertibleDebitInterestSettledWithCommonStockIssuance
302274
CY2017 omex Additional Professional Fees
AdditionalProfessionalFees
80509
CY2017 omex Operations And Research Expense
OperationsAndResearchExpense
3438389
CY2017 omex Expedition Charter Revenue
ExpeditionCharterRevenue
1236623
CY2017 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-7759472
CY2017 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
8209539 shares
CY2017 omex Number Of Financial Institutions In Which Cash Deposited
NumberOfFinancialInstitutionsInWhichCashDeposited
1 Institution
CY2017 omex Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan
CY2017 omex Short Term Investments Maturity Period
ShortTermInvestmentsMaturityPeriod
P3M
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1778461
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
437443 shares
CY2016 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
3.46
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-578674
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2016 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
50000
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
15233928
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Depreciation
Depreciation
1063267
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
CY2016 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
992595
CY2016 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3402416
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
992595
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2186550
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4189828
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-855011
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-65082
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-1083185
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-297837
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2228070
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
272826
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
204380
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9078075
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-329864
CY2016 us-gaap Interest Expense
InterestExpense
2396994
CY2016 us-gaap Interest Paid
InterestPaid
893502
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
70316
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8305192
CY2016 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
350000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7656202
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-6316021
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2762054
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-10550893
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1472818
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
467396
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
129684
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
200000
CY2016 us-gaap Profit Loss
ProfitLoss
-9078075
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7825000
CY2016 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
383148
CY2016 us-gaap Repayments Of Debt
RepaymentsOfDebt
158798
CY2016 us-gaap Revenues
Revenues
4683035
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7057
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1662978
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P8Y2M12D
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7959122
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
65361 shares
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
32.82
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.74
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
828497
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
22493 shares
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2016 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7564082 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7564082 shares
CY2016 omex Accounts Receivable Reserve
AccountsReceivableReserve
29932
CY2016 omex Accounts Payables Settled As Noncash Consideration For Sale Of Equipment
AccountsPayablesSettledAsNoncashConsiderationForSaleOfEquipment
890598
CY2016 omex Payments For Proceeds From Restricted Cash Held As Collateral
PaymentsForProceedsFromRestrictedCashHeldAsCollateral
10000
CY2016 omex Prior Period Accrued Compensation Paid With Equity Instruments
PriorPeriodAccruedCompensationPaidWithEquityInstruments
177500
CY2016 omex Director Fees Settled With Equity Instruments
DirectorFeesSettledWithEquityInstruments
176664
CY2016 omex Fair Value Of Warrants Issued In Connection With Convertible Debt
FairValueOfWarrantsIssuedInConnectionWithConvertibleDebt
303712
CY2016 omex Operations And Research Expense
OperationsAndResearchExpense
8267401
CY2016 omex Expedition Charter Revenue
ExpeditionCharterRevenue
4675978
CY2016 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-6316021
CY2016 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
7564082 shares
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2017Q1 us-gaap Gross Profit
GrossProfit
649353
CY2017Q1 us-gaap Profit Loss
ProfitLoss
-2199263
CY2017Q1 us-gaap Revenues
Revenues
649353
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.01
CY2016Q1 us-gaap Gross Profit
GrossProfit
582477
CY2016Q1 us-gaap Profit Loss
ProfitLoss
84644
CY2016Q1 us-gaap Revenues
Revenues
582477
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2016Q2 us-gaap Gross Profit
GrossProfit
1217318
CY2016Q2 us-gaap Profit Loss
ProfitLoss
-1858778
CY2016Q2 us-gaap Revenues
Revenues
1217318
CY2016Q2 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
2 Directors
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2017Q2 us-gaap Gross Profit
GrossProfit
587270
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-1916885
CY2017Q2 us-gaap Revenues
Revenues
587270
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2016Q3 us-gaap Gross Profit
GrossProfit
2883240
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-2132303
CY2016Q3 us-gaap Revenues
Revenues
2883240
CY2016Q3 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
2 Directors
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2017Q3 us-gaap Gross Profit
GrossProfit
11854
CY2017Q3 us-gaap Profit Loss
ProfitLoss
-2251097
CY2017Q3 us-gaap Revenues
Revenues
11854
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2016Q4 us-gaap Profit Loss
ProfitLoss
-2409584
CY2016Q4 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
2 Directors
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2017Q4 us-gaap Profit Loss
ProfitLoss
-1392227

Files In Submission

Name View Source Status
0001193125-18-095089-index-headers.html Edgar Link pending
0001193125-18-095089-index.html Edgar Link pending
0001193125-18-095089.txt Edgar Link pending
0001193125-18-095089-xbrl.zip Edgar Link pending
d490994d10k.htm Edgar Link pending
d490994dex211.htm Edgar Link pending
d490994dex231.htm Edgar Link pending
d490994dex311.htm Edgar Link pending
d490994dex312.htm Edgar Link pending
d490994dex321.htm Edgar Link pending
d490994dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g490994g0309211515772.jpg Edgar Link pending
g490994g0313064257202.jpg Edgar Link pending
g490994g2.jpg Edgar Link pending
omex-20171231.xml Edgar Link completed
omex-20171231.xsd Edgar Link pending
omex-20171231_cal.xml Edgar Link unprocessable
omex-20171231_def.xml Edgar Link unprocessable
omex-20171231_lab.xml Edgar Link unprocessable
omex-20171231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending